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Abstract
Acidity at surface of cancer cells is a hallmark of tumor microenvironments, which does not depend on
tumor perfusion, thus it may serve as a general biomarker for targeting tumor cells. We used the pH (low)
insertion peptide (pHLIP) for decoration of liposomes and niosomes. pHLIP senses pH at the surface of cancer
cells and inserts into the membrane of targeted cells, and brings nanomaterial to close proximity of cellular
membrane. DMPC liposomes and Tween 20 or Span 20 niosomes with and without pHLIP in their coating
were fully characterized in order to obtain fundamental understanding on nanocarrier features and facilitate
the rational design of acidity sensitive nanovectors. The samples stability over time and in presence of serum
was demonstrated. The size, ζ-potential, and morphology of nanovectors, as well as their ability to entrap a
hydrophilic probe and modulate its release were investigated. pHLIP decorated vesicles could be useful to
obtain a prolonged (modified) release of biological active substances for targeting tumors and other acidic
diseased tissues.
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Introduction
About a century ago, Paul Ehrlich floated the idea of
realizing “magic bullets” to specific and more effective
delivery of drugs [1]. The “magic bullets” should be able
to protect the delivered drug from a harsh environment,
decrease the side effects by targeting drug to diseased
tissue, improving drug pharmacokinetic and pharmaco-
dynamic, and modulating drug release [2].
In 1965, Bangham observed phospholipid-based vesicles
for the first time [3] and, in the following years, Gregory
Gregoriadis established the concept that liposomes could
encapsulate drugs and then be used as drug delivery sys-
tems. In particular, they are composed by phospholipid
closed bilayers (lamellae), where the hydrophobic lipid
chains are closed between two hydrophilic headgroups
layers. The closed bilayer surrounds an aqueous core, thus
allowing for the localization of lipophilic or hydrophilic
drugs respectively [4, 5].
Liposome size is a critical parameter in influencing the
carrier fate after administration, in terms of plasma pro-
teins absorption, recognition by reticuloendothelial sys-
tem (RES), circulation half time, and cellular trafficking.
Nanosized carriers can favor cell internalization and
tumor targeting, thus many researchers have been focus-
ing on “nanonization” [6–9].
In order to obtain more versatile and more economic
nanocarriers, synthetic surfactants have been employed to
obtain liposome-like drug delivery systems. Non-ionic sur-
factants are widely used at this purpose, and are able to
self-assemble into unilamellar or multilamellar vesicles
(non-ionic liposomes, niosomes, or non-ionic surfactant
vesicles). Sorbitan esters surfactants (Spans®) are lipo-
philic substances widely used in niosome preparation.
In order to prolong the vesicles circulation time and
obtain “stealth” nanocarriers, polyethylene glycol (PEG)
incorporation is a gold standard approach: through this
conjugation, ethoxyethylatedsorbitan esters surfactants
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(Tweens®) are obtained. Both Span and Tween are char-
acterized by a different hydrophilic/lipophilic balance
(HLB) value and the choice of the surfactant allows
preparing niosomes with the desired properties [10].
Furthermore, the addition of cholesterol is used for the
enhancement of the bilayer stability by stretching out
the surfactant tails, affecting surfactant’s gel to liquid
phase transition temperature and conferring rigidity of
the lipophilic bilayer [11, 12].The “optimized” nanocar-
rier is designed to improve formulation and/or enhance
targeting [10].
Nowadays, cancer is one of the main causes of death in
the world. Current therapeutic approaches have a number
of limitations including non-efficient drug delivery to tu-
mors and lack of tumor targeting associated with undesir-
able and dangerous side effects, which nanotechnology
approaches might help to overcome [13].
Currently, various targeting approaches are under de-
velopment. Most of them are based on the targeting of
particular biomarkers overexpressed on the surface of
cancer cells. However, due to the fact that human tu-
mors are very heterogeneous, more general approaches
of tumor targeting will be much more advantageous.
Acidity at the surface of cancer cells is a hallmark of
tumor microenvironments, and it does not depend on
tumor perfusion, thus it may serve as a general bio-
marker for targeting tumor cells [14]. pH (low) insertion
peptide (pHLIP) technology is rapidly developing for tar-
geting imaging and therapeutic small molecules, as well
as nanomaterials to tumors. pHLIP senses pH at the sur-
face of cancer cells and inserts into the membrane of
targeted cells [15, 16]. The insertion mechanism of pHLIP
is triggered by the protonation of negatively charged resi-
dues of the peptide at low pH (pH < 7.0). This leads to an
increase of peptide’s hydrophobicity thus shifting the equi-
librium toward partitioning of the peptide into the bilayer
[17]. Nanocarriers decorated with pHLIPs are biocompat-
ible, can target tumors, and demonstrate enhanced cellu-
lar uptake by cancer cells. Among investigated pHLIP-
coated nanoparticles are lipid, polymer, and metal-based
nanomaterials [18–21].
The aim of the present work is to fully characterize
novel vesicular nanocarriers decorated by pHLIP in
order to obtain fundamental understanding on nanocar-
rier features and facilitate the rational design of acidity
sensitive nanovectors.
Materials and Methods
Materials
Polyoxyethylenesorbitan monolaurate (Tween 20), sorb-
itan monolaurate (Span 20), cholesterol (Chol), Hepes
salt {N-(2-idroxyethyl) piperazine-N′-(2-ethanesulfonic
acid)}, human serum, Sephadex G-75, calcein, and
diphenylhexatriene (DPH) were purchased from
Sigma-Aldrich. 1,2-Dimyristoyl-sn-glycero-3-phosphocho-
line (DMPC) and 1,2-dioleoyl-sn-glycero-3-phosphoetha-
nolamine-N-[4-(p-maleimidophenyl)butyramide] so-
dium salt (DSPE-maleimide) were purchased from
Avanti Polar Lipids and pyrene was obtained from Fluka.
pHLIP peptide (ACEQNPIYWARYADWLFTTPLLLLD
LALLVDADEGT) was synthesized and purified by CS Bio.
All other products and reagents were of analytical grade.
Synthesis of DSPE-pHLIP
pHLIP was conjugated with DSPE lipids in methanol by
the covalent conjugation of DSPE-maleimide with the sin-
gle cysteine residue at the N-terminus of pHLIP, as it was
described previously [18, 21, 22]. Briefly, 5 mg of peptide
dissolved in 250 μL methanol (blown with argon) and
DSPE-maleimide (from 9.9 mM stock solution) dissolved
in chloroform were mixed at a molar ratio of 1:1. Reaction
mixture was kept at room temperature for about 2–6 h
until the conjugation was completed. The reaction pro-
gress in conjugation of DSPE-malemide with pHLIP was
monitored by the RP-HPLC using a gradient from 25 to
80% acetonitrile in water containing 0.05% TFA by moni-
toring a decrease of peak corresponding to the unlabeled
pHLIP in the reaction mixture. The synthesized construct
was characterized by SELDI-TOF mass-spectrometry. The
concentration of DSPE-pHLIP conjugate was determined
by absorbance using the molar extinction coefficient for
pHLIP: ε280 = 13,940 M
−1 cm−1.
Vesicles Preparation and Purification
The thin layer evaporation method was used to prepare
non-ionic surfactant (from Tween 20 or Span 20) and
phospholipid (from DMPC) vesicles, with and without
pHLIP. In each vesicle formulation, cholesterol was
added in different molar ratios (Table 1) [23].
Sample composition has been optimized choosing pre-
viously well-characterized structures [24, 25] at which
the same amount of pHLIP has been added.
The lipophilic components were first dissolved in
CHCl3:CH3OH mixture (3:1); the organic solvent was
then removed under vacuum at different temperatures de-
pending on the sample. The obtained film was hydrated
with 5 mL of Hepes buffer (0.01 M pH 7.4) or sodium cal-
cein solution 10−2 M. The suspension was vortex-mixed
for about 5 min, followed by sonication (see Additional file
1: Table S1, supporting information) using a microprobe
operating at 20 kHz (VibraCell-VCX 400-Sonics, Taunton,
MA, USA). LipoDMPC sonication was conducted under
inert atmosphere to prevent oxidation.
The vesicle suspension was then purified by gel per-
meation chromatography using Sephadex G-75 (glass
column of 50 × 1.2 cm) and Hepes buffer as eluent.
Afterwards, the purified vesicle suspension was filtered
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by means of cellulose filters with the appropriate pore
diameter.
The same preparation method was used to prepare
pHLIP-coated niosomes and liposomes.
Dynamic Light Scattering Measurements
The average size and size distribution of the vesicles
were measured at T = 25 °C by dynamic light scattering
(DLS), using a Malvern NanoZetaSizer ZS90, equipped
with a 5 mW HeNe laser (wavelength λ = 632.8 nm) and
a digital correlator. The normalized autocorrelation
functions of the scattered intensity at 90° angle were an-
alyzed by the Contin algorithm to obtain the distribution
of the particles diffusion coefficient D, hence the distri-
bution of the effective hydrodynamic radius RH of the
vesicles via the Stokes-Einstein relation RH = KBT/6πηD,
where KBT is the thermal energy and η is the solvent vis-
cosity. The width of the size distribution of niosomes/li-
posomes is rather small but non-negligible. The values
reported in Table 2 correspond to the intensity-weighted
average hydrodynamic diameter of the particles [26].
ζ-Potential Measurements
The electrophoretic mobility measurements were car-
ried out by the laser Doppler electrophoresis technique,
using the Malvern NanoZetaSizer ZS90 apparatus. The
mobility u was converted into the ζ-potential using the
Smoluchowski relation ζ = uη/є, where η and є are the
viscosity and the permittivity of the solvent phase, re-
spectively [27].
Small Angle X-Ray Scattering
Small angle X-ray scattering (SAXS) experiments were
carried out at European Synchrotron Radiation Facility
(ESRF, Grenoble, France). The use of the ID02 high-bril-
liance beamline allowed to perform measures on dilute
solutions in the region of momentum transfer
0.1 nm−1 ≤ q ≤ 6 nm−1, q = (4π/λ)sin(θ/2), where θ is the
scattering angle and λ = 0.1 nm the X-ray wavelength.
The corresponding investigated length-scale is between
1 and 60 nm, suitable for accessing the internal structure
of niosomal and liposomal vesicles. All experiments
were performed at T = 25 °C with short irradiation
time, 0.1 s, to prevent radiation damage. For each
sample, the scattered intensity at different scattering
angles was captured on a 2D detector, then angularly
regrouped, subtracted for the background and solv-
ent contributions, and analyzed to obtain information
on the shape and internal structure of the vesicles in
solution.
In the case of unilamellar vesicles, the closed bilayer
was modeled with three concentric shells corresponding
to the external headgroups, the hydrophobic chains, and
the internal headgroups. A Schulz distribution for the
vesicle size was assumed.
Cryo-TEM
Vesicle solution (5 μL droplet) was spread on a Lacey
formar/carbon electron microscopy grid and preserved
in a frozen-hydrated state by a rapid freezing in liquid
ethane. The vitrification process was performed using
FEI Vitrobot system with the setting of a single blot of
3 s, an offset of 1, and drain and waiting time of 1 s.
Transmission electron microscopy (TEM) (JEOL 2100)
with an accelerating voltage of 200 kV at magnifications
in the range of × 10,000 to × 150,000 was used to image
vesicles.
Stability Studies
Physical stability studies of niosomes and liposomes,
prepared with and without pHLIP, were carried out at
two different storage temperatures (25 °C and 4 °C). The
aim was to evaluate if significant changes in size and
ζ-potential of the vesicles dispersion occur over a period
Table 1 Sample composition
Sample Tween 20 (mM) Span 20 (mM) DMPC (mM) Chol (mM) DSPE-pHLIP (mM)
NioTween20 15.0 – – 15.0 –
NioSpan20 – 15.0 – 15.0 –
LipoDMPC – – 49.4 29.7 –
NioTween20-pHLIP 15.0 – – 15.0 0.1
NioSpan20-pHLIP – 15.0 – 15.0 0.1
LipoDMPC-pHLIP – – 49.4 29.7 0.1
Table 2 Samples characterization in hydrodynamic diameter, ζ-
potential, and PDI
Sample Hydrodynamic
diameter ± SD
ζ-Potential
(mV) ± SD
PDI
NioTween20 162.0 ± 2.0 − 22.8 ± 0.2 0.26
NioTween20-pHLIP 168.5 ± 2.3 − 19.5 ± 0.6 0.37
NioSpan20 165.5 ± 3.3 − 36.4 ± 0.9 0.35
NioSpan20-pHLIP 156.3 ± 1.0 − 38.4 ± 2.3 0.21
LipoDMPC 139.7 ± 2.4 − 15.9 ± 0.4 0.15
LipoDMPC-pHLIP 129.8 ± 2.0 − 10.8 ± 0.4 0.13
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of 90 days. Samples from each batch were withdrawn at
definite time intervals (1, 30, 60, and 90 days) and the
vesicles size and ζ-potential were determined as previ-
ously described.
Similarly, the vesicles stability was investigated also in
the presence of biological fluids, such as human serum.
The suspensions were contacted with 45% of human
serum at 37 °C. At definite time intervals (0, 30 min, 1 h,
2 h, and 3 h), variations in vesicle size and ζ-potential were
determined as described.
Bilayer Characterization
Fluidity and microviscosity-polarity of niosomal and lipo-
somal bilayers were accessed by fluorescence measure-
ments of two fluorescent probes, diphenylhexatriene
(DPH) and pyrene, respectively, located in the hydropho-
bic region of the bilayer membrane. Both DPH (2 mM)
and pyrene (4 mM), 220 μL and 2.5 mg respectively, were
added to the surfactant or phospholipid/cholesterol mix-
ture before vesicle preparation [28]. Afterwards, pyrene-
loaded vesicles were purified as previously described,
while DPH-loaded vesicles were filtrated through progres-
sively smaller pore size (from 5.0 to 0.22 μm).
The fluorescence anisotropy measurements were car-
ried out at room temperature using an LS55 spectrofluo-
rometer (PerkinElmer, MA, USA) at λexc = 400 nm and
λem = 425 nm and the fluorescence anisotropy (A) of
samples was calculated according to the following equa-
tion [29]:
A ¼ Ivv−Ivh x G
Ivv þ 2Ivh x G
where Ivv and Ivh are the intensities of the emitted fluor-
escence (arbitrary units), respectively, parallel and per-
pendicular to the direction of the vertically polarized
excitation light. The correction factor G = Ihv/Ihh is the
ratio between the vertically and the horizontally polar-
ized emission components when the excitation light is
horizontally polarized. The fluorescence anisotropy
values are inversely proportional to membrane fluidity.
Therefore, high fluorescence anisotropy value corre-
sponds to a high structural order and/or low membrane
fluidity [30].
In order to evaluate the microviscosity and the micro-
polarity of the vesicle bilayer, fluorescence experiments
with pyrene were carried out with a Perkin-Elmer LS55
spectrofluorometer at λexc = 330 nm, recording the emis-
sion spectrum in the range 350 < λem < 550 nm [28]. The
fine structure of pyrene fluorescence presents five peaks.
The ratio between the intensities of the first (372 nm)
and the third (382 nm) vibrational bands of the pyrene
fluorescence spectrum, I1/I3, is related to the polarity of
the pyrene environment [31]. Indeed, low values of the
I1/I3 ratio correspond to a nonpolar environment. Fur-
ther, pyrene molecules incorporated into the vesicle bi-
layer may form intramolecular excimers and this process
is sensitive to the viscosity of the probe microenviron-
ment [32]. Therefore, the excimer/monomer fluores-
cence intensity ratio, IE/IM, is related to microviscosity.
These studies were carried out on the vesicles pre-
pared both with and without pHLIP and the obtained re-
sults were then compared.
Calcein Release Studies
Non-ionic surfactant or phospholipid vesicles were
loaded with calcein at concentration of 10−2 M. At this
concentration, the calcein fluorescence is self-quenched
[33]. Dequenching measurements were then used to de-
termine the calcein release from the vesicle aqueous
core. The fluorescent probe was loaded into the vesicles
during hydration of the thin film by addition of 5 mL of
the calcein aqueous solution. The vesicle suspensions
were purified by gel permeation chromatography, con-
tacted with 45% human serum or Hepes, and then
loaded inside a cellulose membrane dialysis bag (cut-off
molecular weight 8.000 Da from Spectra/Por®). The re-
lease experiments were carried out at 37 °C, under mag-
netic stirring in Hepes buffer (10 mM, pH 7.4) as an
external medium. Aliquots of the external medium were
withdrawn at different times over 0–24 h. From time to
time, the withdrawn aliquots were reintroduced in the
system [34].
The calcein release was monitored by measurements
of the fluorescence of the medium using a Perkin-Elmer
LS50B spectrofluorometer with λex = 492 and λem =
520 nm. The reference value F∞ (arbitrary units), corre-
lated to the total calcein amount entrapped in the vesi-
cles [35], was determined after the disruption of the
vesicles using isopropyl alcohol (1:1 v/v). The release
percentages (F%) at each time point were obtained using
the following equation:
F% ¼ Ft=F∞x 100
where Ft (arbitrary units) is the fluorescence read at a
specific time point t.
Statistical Analysis
A one-way ANOVA was used for statistical analysis. A
posteriori Bonferroni t test was carried out to evaluate
the statistical significance of the ANOVA test. A p value
< 0.05 was considered statistically significant. Results are
the average of three experiments ± standard deviation.
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Results and Discussion
Tween20-, Span20-, and DMPC-vesicles, prepared with
and without DSPE-pHLIP, were characterized for size
and ζ-potential (Table 2).
According to the results presented in Table 2, the ana-
lyzed samples do not show significant variations in ei-
ther size or ζ-potential, regardless the pHLIP presence.
The above reported size ranges were confirmed by
means of a different analysis technique, such as the cryo-
TEM (Fig. 1).
The internal structure of niosomes/vesicles with and
without DSPE-pHLIP was determined by SAXS experi-
ments. The SAXS intensity spectra, presented in Fig. 2,
are different, indicating that each system has peculiar
features.
Tween20-based niosomes are unilamellar, while DMPC
vesicles display a certain degree of multilamellarity (as lipo-
somes), as shown by the presence of the characteristic peak
at q ≅ 1 nm−1, corresponding to an interlamellar distance of
6 nm (about 5 nm lipid bilayer and 1 nm water). Span20-
based vesicles are definitely multilamellar, with a character-
istic peak at q = 1.6 nm−1 corresponding to an interlamellar
distance of 3.8 nm, matching twice the length of the
Span20 molecule. Results indicate that the multilayered
shell of Span20 vesicles is composed of adjacent bilayers
with almost no interlamellar water.
The presence of DSPE-pHLIP (less than 1% mole frac-
tion) does not dramatically affect the systems. The scat-
tered intensity in all the investigated q-range is quite
similar, indicating comparable fraction of structured
material and comparable overall size of the vesicular
particles.
DMPC-based vesicles show a slight increase in the
number of bilayers within the liposome, as deducible by
the intensity increase of the Bragg peak at q = 1 nm−1.
The insertion of a low fraction of DSPE C18-chains,
linked to each peptide molecule, does not change the
thickness of the lipid bilayer, and mainly dictated by the
large fraction of cholesterol with respect to DMPC
(about 40–50%). At this concentration of cholesterol,
lipid chains are organized in the liquid ordered (Lo)
phase, and characterized by the decoupling of the weak
lateral positional order of the chains with respect to the
high orientational order along the chains and capable of
hosting few C18-chains without any structural change
[36]. Also Span20-based multilayered vesicles display no
changes in their internal structure.
In the Tween20 + pHLIP system, a small amount of
cholesterol crystallites is present, as shown by the typical
sharp peak at q = 1.84 nm−1 (characteristic distance of
3.41 nm), and the vesicle structure is unaffected. The
presence of few microcrystallites has been often found
associated with Tween-based niosomes [37] in amount
depending on composition, preparation procedure, and
Fig. 1 Representative cryo-TEM images of niosomes and liposomes
coated with pHLIP. Images of NioSpan20-pHLIP niosomes (a) and
LipoDMPC-pHLIP liposomes (b) obtained at × 10,000 magnification
and LipoDMPC-pHLIP liposomes (c) obtained at × 40,000 magnification
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purification. In Fig. 2, the two experimental spectra of
Tween20 and Tween20 + pHLIP vesicles are shown to-
gether with the fitting curves obtained by modeling the
spherically closed bilayer with three concentric shells: the
external headgroups, the chains, and the internal head-
groups. The fitting average size of vesicles is about
168 nm in both systems, in agreement with DLS results.
Structural parameters are the same for the two closed
bilayers (see Additional file 1: Figure S1 and Table S2)
except for the external shell: in the presence of
DSPE-pHLIP, a slight decrease (5%) of the electron density
of the headgroups is observed (from 0.42 to 0.40 e/Å3), to-
gether with an increase in the roughness of the layer. This
result indicates that addition of DSPE-pHLIP mainly af-
fects the external shell of the vesicles. This is consistent
with a picture where the DSPE C18-chains insert into the
bilayer and anchor the peptide to the vesicle surface,
among the extended and ramified polyethylene-glycol
headgroups. We note that the ability of pHLIP peptide it-
self (not linked to the lipid molecules) to interact with the
external surface of vesicles at high pH and insert into bi-
layer at low pH has been recently observed by SAXS in
the case of unsaturated phospholipid bilayers [38]. In the
present study, the mole fraction of peptide is significantly
lower and peptide is linked to lipids, as the goal is to de-
sign pHLIP-coated pH-sensitive drug nanovectors. The
pHLIP association is driven by the hydrophobic inter-
action of the conjugated DSPE C18-chains inserting in the
hydrophobic region of the nanovector. The pHLIP peptide
is anchored and lies in the external headgroup region,
prone to interact with target membranes at acidic pH
and/or to release the nanovector content after bilayer
rearrangement in low pH environment.
To investigate whether the pHLIP presence could affect
bilayer microrheological properties (fluidity, microviscos-
ity, and polarity), a lipophilic shell characterization was
carried out. The characterization studies were conducted
by using the fluorescent probe pyrene, added to the sam-
ples at the beginning of the preparation procedure. Due to
its lipophilic nature, it inserts into the vesicle bilayer and
provides information about the polarity and microviscosity
of the membrane environment.
As shown in Table 3, in all of three samples sets, polarity
values just slightly decrease in the presence of pHLIP
compared to the counterpart vesicle without pHLIP, while
microviscosity values show a threefold increase, for all
vesicles.
The bilayer was further characterized by measure-
ments of fluorescence anisotropy of another lipophilic
fluorescent probe, DPH, incorporated into lipids. These
measurements reflect the probe movement and its
orientation within the bilayer which gives information
on the bilayer fluidity that can affect the vesicles capabil-
ity to release their content [29]. Fluorescence anisotropy
values are inversely proportional to the membrane fluid-
ity. Hence, high fluorescence anisotropy value corre-
sponds to a high structural order and/or low membrane
fluidity, as in liquid-ordered phase [30].
The anisotropy values for each sample are shown in
Table 3. The data indicate that the presence of the
Fig. 2 SAXS spectra. Intensity spectra of niosomes/vesicles without (black open symbols) and with DSPE-pHLIP (color symbols)
Table 3 I1/I3 (polarity), IE/I3 (microviscosity) and fluorescence
anisotropy values of the vesicle bilayer
Sample Polarity
(I1/I3)
Microviscosity
(IE/I3)
Fluidity
(anisotropy)
NioTween20 1.12 0.42 0.20
NioTween20-pHLIP 0.97 1.20 0.10
NioSpan20 0.97 0.38 0.30
NioSpan20-pHLIP 0.91 1.21 0.10
LipoDMPC 0.96 0.38 0.24
LipoDMPC-pHLIP 0.95 1.18 0.18
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DSPE-pHLIP in the vesicles increases membrane flu-
idity, since the fluorescence anisotropy decreased. It
is well known that the bilayer fluidity is affected not
only by order and lateral organization of the apolar
chains but also by the polar headgroups [31]. SAXS
results on the three different systems show that DSPE-
pHLIP molecules affect mainly the headgroup region,
eventually causing a different packing of the polar
heads. Structural results seem to match with micro-
rheological properties of the bilayers in presence of as-
sociated DSPE-pHLIP as revealed by the insertion of
two different probes. Results show an increased micro-
viscosity as revealed by pyrene, a probe that could in-
sert close to the outer region (pyrene log P is 4.88).
On the other hand, DPH is assumed to be embedded
in the core of the bilayers, oriented parallel to the lipid
acyl chain axis or constrained in the center of the bi-
layer, parallel to the surface. It is largely sensitive to
the angular reorientation of amphiphile acyl chains
[39]. The increased fluidity, as revealed by DPH, could
be related to both the effect of the insertion of DSPE
chains among the other acyl chains and to the effect
of pHLIP partition in the polar headgroups region,
changing the packing properties of the surfactants.
(Fig. 3).
Further characterization studies were conducted
on the examined preparations. All the samples, pre-
pared with and without pHLIP, were stored for
90 days at 4 °C temperature in order to evaluate
stability of the vesicles over time, by measuring their
size and ζ-potential variations (Additional file 1: Figure S2).
No significant variations in size and ζ-potential were
observed along the experiment; therefore, all the ex-
amined preparations resulted stable if stored at 4 °C
temperature.
In addition, stability of the samples was examined in
the presence of 90% (v/v) human serum and stored at
37 °C for 3 h (Additional file 1: Figure S3).
In contact with human serum, Tween20 vesicles showed
an increase in size, although remained below 300 nm. The
size and the PDI values were measured to be constant
along the 3-h experiment, suggesting that the vesicles in
suspension remained intact along the entire experiment.
Both the Span20 samples in contact with human serum
showed an increase in size, especially in the preparation
with pHLIP, while PDI values suggest a homogeneous size
distribution (data not shown). This event can be due to
the absorption of plasma proteins on the niosomal surface,
as result of electrostatic interactions, however, without in-
curring in vesicles disruption. This hypothesis is sup-
ported by the ζ-potential decrease after the vesicles
contact with human serum. This phenomenon occurs
when the ζ-potential reaches slightly negative values,
around the neutrality region, making the system to be un-
stable, and vesicles start aggregating.
As well as Tween20, DMPC vesicles show an increase
in size in comparison to the pre-contact sample. How-
ever, this variation turned out to be non-significant and
the size values maintained under 280 nm (DMPC) or
under 240 nm (DMPC + pHLIP).
The release capability was evaluated for the samples
prepared with and without pHLIP following the amount
of calcein (hydrophilic probe) released from the vesicles
over the time.
The studies were carried out at the temperature of 37 °C
for a time period of 24 h, by exposing of the purified sam-
ples with either HEPES buffer or human serum. As shown
in the Fig. 4, calcein release profiles turn out to be very
similar for both Tween20 and Tween20-pHLIP in HEPES
buffer or human serum.
Fig. 3 Representation of pHLIP interactions with vesicle membrane
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The released amount of calcein was in between 30 and
50% indicating no differences in the release capabilities
between the samples prepared with and without pHLIP.
Same results have been obtained for Span and DMPC
samples (data not shown).
Comparable release profiles have been reported for dif-
ferent stimuli-responsive nanocarriers, such as thermo-
sensitive cubosomes [40] or polymeric self-assembled
nanocarriers (SANs) [41, 42].
In conclusion, the physico-chemical differences ob-
served in terms of microviscosity and fluidity for the
samples prepared with and without pHLIP (Table 3) do
not affect their release capabilities (Fig. 4), according to
the evidence that the insertion of DSPE-pHLIP mole-
cules affect mainly the headgroup region. These data are
in agreement with previously reported results showing
that at neutral and high pHs, pHLIP is bound to the sur-
face of liposomes made by 1-Palmitoyl-2-oleoyl-sn-gly-
cero-3-phosphocholine (POPC) and does not induce
fusion or membrane leakage.
Conclusion
This study confirms the possibility of preparing pHLIP
decorated vesicles. Samples are stable if stored at 4 °C
temperature for at least 3 months and in the presence
of serum. Furthermore, proposed nanovectors are able
to entrap a hydrophilic probe and to modulate its
release.
pHLIP vesicles were fully characterized in order to ob-
tain fundamental understanding on nanocarrier features
and facilitate the rational design of acidity sensitive
nanovectors.
The pHLIP association is driven by the hydrophobic
interaction of the conjugated DSPE C18-chains insert-
ing in the hydrophobic region of the nanovector. The
pHLIP peptide is anchored and lies in the external
headgroup region, prone to interact with target membranes
at acidic pH and/or to release the nanovector content
after bilayer rearrangement in low pH environment.
According to these findings, proposed pHLIP deco-
rated vesicles could be useful to obtain a prolonged
(modified) release of biological active substances for
targeting tumors and other acidic diseased tissues.
Additional file
Additional file 1: Table S1. Parameters for the preparation of several
samples with and without pHLIP. Figure S1. SAXS intensity spectra of
TWEEN20 based vesicles without (black dots) and with (red dots) pHLIP,
together with the fitting curves obtained with a multishell model. The
core has the same electron density of the solvent (water) and the three
shells are constituted by the inner headgroups layer, the hydrophobic
layer, the outer headgroups layer. Parameters, thickness and electron
density are reported in the Table S2. Table S2. Parameters, thickness and
electron density obtained by SAXS analysis. Figure S2. Samples stability
in terms of size and ζ-potential variations over time. Figure S3. Z-Average
variations for all samples in contact with human serum. The ζ-potential
values are around -7 mV for all samples. (DOCX 635 kb)
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